Metabolism and bioavailability of trans-resveratrol.
By E. Wenzel, V. Somoza. Molecular Nutrition & Food Research, 2005
709 citations recorded by the source corpus.
Subfields: Geriatrics and Gerontology, Inorganic Chemistry, Nutrition and Dietetics
View Paper: https://www.semanticscholar.org/paper/368d6d43e7aaf5a0e959352eacafe66548146236
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- M. Gómez-Cabrera
- R. López-Grueso
- Vicent Bonet-Costa
- C. Mas-Bargues
- Lucía Gimeno-Mallench
- C. Borrás
- J. Viña
- T. Thompson
Citations in the corpus
- Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans (2015, background): “This may be explained by the conversion of both sulfates and glucuronides again to resveratrol in target organs such as the liver [44, 46].”
- Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats (2010, background): “Low plasma and tissue levels of resveratrol have been reported following oral administration to both experimental animals and humans [6, 41, 44]; reported in vivo plasma levels are significantly lower than are the concentrations of resveratrol that have commonly been used in static, metabolism-, and”